The IX International conference "White nights of hepatology 2017""Hepatitis C 2017: optimizing treatment for every patient"
under the aegis of EASL
Event dates: 08-09 June '17
Number of participants: 1000
Event venue: Hotel "Crowne Plaza St.Petersburg Airport" (Saint Petersburg, Startovaya str., 6)
BIOCAD is an innovative biotechnology company involved in the entire life cycle of medicinal products. BIOCAD is a modern company with its own world-class R&D center and the manufacturing facilities complying with GMP regulations. The company produces a wide range of medicinal products for the treatment of cancer, autoimmune diseases, and various infections. Development and manufacture of antiviral medicinal products are important areas of the company’s focus.
In 2013, BIOCAD launched Algeron® (INN: cepeginterferon alfa-2b), the first Russian original product of pegylated interferon alfa for the treatment of chronic hepatitis C. Now, Algeron® is successfully used in the clinical practice, either as dual therapy with ribavirin (treatment for chronic hepatitis C) or in combination with direct-acting antivirals. So far, more than 16 000 patients have received Algeron® treatment, according to the internal data.
In 2015, Algeron® was awarded as “Innovative front-line therapy for HCV infection” by Russian Pharma Awards and also took the lead in the prize contest “The best innovative product” held by the Government of Saint Petersburg.
In 2016, BIOCAD released three anti-HIV-1 medicinal products for antiretroviral therapy:
Zilacomb®, a fixed-dose combination of zidovudine plus lamivudine;
Tenofovir (INN: tenofovir);
Emtricitabine (INN: emtricitabine).
In addition, BIOCAD received marketing authorization for Darunavir (INN: darunavir) in 2016.
BIOCAD constantly monitors the safety of its medicinal products during their clinical use. The company employs its own pharmacovigilance system, which accumulates safety data received from both clinicians and patients.
34-A, Ul. Svyazi, Strelna, Saint Petersburg, Russian Federation, 198515